Compare OPHC & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPHC | PDSB |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.9M | 46.0M |
| IPO Year | N/A | N/A |
| Metric | OPHC | PDSB |
|---|---|---|
| Price | $4.16 | $0.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 26.6K | ★ 968.1K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.25 | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $43,818,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.21 | ★ N/A |
| Revenue Growth | ★ 26.98 | N/A |
| 52 Week Low | $3.53 | $0.70 |
| 52 Week High | $5.15 | $2.46 |
| Indicator | OPHC | PDSB |
|---|---|---|
| Relative Strength Index (RSI) | 53.71 | 50.47 |
| Support Level | $4.13 | $0.70 |
| Resistance Level | $4.22 | $0.82 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 47.22 | 58.70 |
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.